Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer.
Daniel P HurkmansEdwin A BasakNina SchepersEsther Oomen-De HoopCor H Van der LeestSamira El BouazzaouiSander BinsStijn L W KoolenStefan SleijferAstrid A M Van der VeldtReno DebetsRon H N Van SchaikJoachim G J V AertsRon H J MathijssenPublished in: Journal for immunotherapy of cancer (2021)
Dutch Trial Registry (NL6828).